CD79A and rheumatoid arthritis: Alongside the increased Treg numbers observed in our feasibility study, RA patients also showed beneficial Th1/Th17 cell ratios, lowered citrullinated vimentin peptide 18 and serum IgA concentrations, and improved parameters for quality of life, as shown by the HAQ and SF36 questionnaire outcomes.